PCM
EXAS

Pentwater Capital Management’s Exact Sciences EXAS Stock Holding History

Pentwater Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,250,000
Closed -$736M – 101
2025
Q4 		$736M Buy
+7,250,000
New +$582M 3.87% 10
2020
Q1 		– Sell
-10,000
Closed -$925K – 137
2019
Q4 		$925K Sell
10,000
-19,000
-66% -$1.67M 0.02% 104
2019
Q3 		$2.62M Buy
+29,000
New +$3.3M 0.04% 85

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Pentwater Capital Management's EXAS Position: Q1 2026 in Review

Pentwater Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 7,250,000 shares — an estimated $736M sold.

Pentwater Capital Management first reported a position in EXAS in Q3 2019 and held it in 3 quarters. The position peaked at $736M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Pentwater Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Pentwater Capital Management sold 7,250,000 Exact Sciences shares in Q1 2026, an estimated $736M.
  • Pentwater Capital Management first reported a position in Exact Sciences in Q3 2019 and held it in 3 quarters.
  • Pentwater Capital Management's Exact Sciences position peaked at $736M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Pentwater Capital Management's 13F filing for Q1 2026, filed 15 May 2026.